XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Class A Common Shares
Class B Common Shares
Common stock
Class A Common Shares
Common stock
Class B Common Shares
Additional paid-in capital
Retained deficit
Treasury stock
Beginning balance (in shares) at Apr. 30, 2020       35,000,649 1,821,587      
Beginning balance at Apr. 30, 2020 $ 119,422     $ 3,500 $ 182 $ 150,312 $ (9,013) $ (25,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Proceeds from stock options exercised (in shares) 462,321     462,321        
Proceeds from stock options exercised $ 4,735     $ 46   4,689    
Stock-based compensation 1,901         1,901    
Net earnings 5,037           5,037  
Dividends declared [1] (10,745)           (10,745)  
Ending balance (in shares) at Jan. 31, 2021       35,462,970 1,821,587      
Ending balance at Jan. 31, 2021 120,350     $ 3,546 $ 182 156,902 (14,721) (25,559)
Beginning balance (in shares) at Oct. 31, 2020       35,277,846 1,821,587      
Beginning balance at Oct. 31, 2020 119,053     $ 3,528 $ 182 154,335 (13,433) (25,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Proceeds from stock options exercised (in shares)       185,124        
Proceeds from stock options exercised 1,882     $ 18   1,864    
Stock-based compensation 703         703    
Net earnings 2,311           2,311  
Dividends declared [1] (3,599)           (3,599)  
Ending balance (in shares) at Jan. 31, 2021       35,462,970 1,821,587      
Ending balance at Jan. 31, 2021 120,350     $ 3,546 $ 182 156,902 (14,721) (25,559)
Beginning balance (in shares) at Apr. 30, 2021   35,629,566 1,821,587 35,629,566 1,821,587      
Beginning balance at Apr. 30, 2021 $ 122,391     $ 3,563 $ 182 159,492 (15,287) (25,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Proceeds from stock options exercised (in shares) 678,129     678,129 [1]        
Proceeds from stock options exercised [1] $ 7,405     $ 67   7,338    
Stock-based compensation 2,910         2,910    
Net earnings 9,201           9,201  
Dividends declared [1] (11,028)           (11,028)  
Ending balance (in shares) at Jan. 31, 2022   36,307,695 1,821,587 36,307,695 1,821,587      
Ending balance at Jan. 31, 2022 130,879     $ 3,630 $ 182 169,740 (17,114) (25,559)
Beginning balance (in shares) at Oct. 31, 2021       36,174,808 1,821,587      
Beginning balance at Oct. 31, 2021 128,847     $ 3,617 $ 182 166,969 (16,362) (25,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Proceeds from stock options exercised (in shares) [1]       132,887        
Proceeds from stock options exercised [1] 1,691     $ 13   1,678    
Stock-based compensation 1,093         1,093    
Net earnings 2,940           2,940  
Dividends declared [1] (3,692)           (3,692)  
Ending balance (in shares) at Jan. 31, 2022   36,307,695 1,821,587 36,307,695 1,821,587      
Ending balance at Jan. 31, 2022 $ 130,879     $ 3,630 $ 182 $ 169,740 $ (17,114) $ (25,559)
[1] Amounts adjusted for rounding